Home / Pharmaceutical company intelligence
Pharmaceutical company intelligence

Platinum Pharmaceuticals

Private pharmaceutical manufacturer · Karachi · Pakistan

Karachi-based pharmaceutical manufacturer serving domestic and export markets from the Bin Qasim industrial zone.

Sourced corporate profile Corporate identity fields are source-tracked; portfolio, price and competitor intelligence remains independently calculated by MedInfoBase.
Official website ↗ Official contact ↗
ShareSend this page
Evidence & freshness

What is sourced, and how recent is it?

Public-source corporate details
Latest regulatory-source observation23 Sep 2026Newest linked source record observed by MedInfoBase
Latest portfolio source check22 Sep 2026Latest source-check date across this published portfolio
Latest effective price date4 Aug 2026Newest effective date among published current price records
Corporate profile evidence4 sourcesCorporate source details checked 16 Aug 2026

Regulatory-source portfolio data and company-supplied/corporate profile fields are tracked separately. Company claim/verification status is separate from source quality. An unclaimed company can still have a fully official-source-observed portfolio.

Regulatory & corporate identity

Company profile

Public-source corporate details
Legal / official name
Platinum Pharmaceuticals (Pvt.) Ltd.
Company type
Private pharmaceutical manufacturer
Address
A-20, North Western Industrial Zone, Bin Qasim, Karachi 75020, Pakistan · 75020
Phone
+92 21 34750112-3
Official contact
Contact page ↗
Corporate source details checked
16 Aug 2026
Corporate profile completeness
88%
DRAP manufacturing licenceAs published by the DRAP Licensing Division. DRAP issues this list for stakeholder review and states it is not a reference for litigation, claims or citation.
Formulation 000415 Platinum Pharmaceuticals (Pvt) Ltd. · Sindh
Source-linked licence identifiersShown as recorded in linked source rows; not a claim of current validity.
DML 000415 161 linked products · source seen 23 Sep 2026 View source ↗
Corporate profile source ledger Contact Page Url source ↗ Logo Source Url source ↗
Location intelligence

Company location

Google Maps
Location recorded

A sourced company location is recorded. Use the map link below for directions.

Open in Google Maps ↗
Intelligence snapshot

Portfolio at a glance

Not sales data · published MedInfoBase database view
Rx162public portfolio records represented
REG108unique registrations represented
IDX161indexed MedInfoBase presentations
SRC1additional source-observed presentations
R+0registry-only registrations
VER0registry-verified exact registrations
PKR152current validated price records
G56generic molecules in indexed catalogue
DF9dosage-form groups
TA10therapeutic areas
How to read these counts

RegistrationA unique regulatory registration number. One registration may have more than one strength/form/pack presentation.

PresentationA distinct medicine presentation, such as a particular strength, dosage form and pack.

IndexedA canonical MedInfoBase presentation that passed MedInfoBase identity and publication controls.

Source observedAn additional presentation observed in an official DRAP source but not counted as an indexed MedInfoBase presentation.

Registry onlyAn exact registry-verified registration not otherwise represented by an indexed or source-observed presentation.

Registry verifiedAn exact registration match found in an official DRAP registry source. This is evidence status, not a commercial ranking.

Data coverage

How complete is this profile?

Current price coverage94%
public portfolio presentations with a validated current price
Official-source coverage100%
products linked back to a source record
Unit-price parse coverage98%
priced packs safely normalized per unit
Comparable-market coverage89%
products with at least one like-for-like comparator
Therapeutic classification100%
products assigned to a broad therapeutic area
Visual intelligence

Downloadable company intelligence charts

Copy or download any chart as a presentation-ready PNG. Every exported chart keeps MedInfoBase attribution and the source company-profile URL.

Shareable intelligence

Therapeutic Portfolio Mix

Shows where the company portfolio is concentrated across broad therapeutic areas.

Therapeutic Portfolio MixPlatinum PharmaceuticalsShare of current product presentations by broad therapeutic areaMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/platinum-pharmaceuticalsGenerated 23 Sep 2026CNS & mental health55 · 34%Anti-infectives45 · 28%Respiratory & allergy19 · 12%Cardiovascular17 · 11%Oncology & immunology6 · 4%Vitamins, minerals & nutrition5 · 3%Reproductive & genitourinary5 · 3%Other therapeutic areas9 · 6%Percentages are based on current product presentations in the MedInfoBase company portfolio.

Portfolio distribution, not sales or market-share data.

Shareable intelligence

Dosage Form Portfolio

Shows how the company portfolio is distributed across tablets, capsules, injections, liquids and other forms.

Dosage Form PortfolioPlatinum PharmaceuticalsDistribution of current product presentations by normalized dosage formMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/platinum-pharmaceuticalsGenerated 23 Sep 2026161presentationsTablet99 · 61%Capsule17 · 11%Suspension15 · 9%Syrup9 · 6%Inhalation8 · 5%Solution7 · 4%Other forms6 · 4%Dosage-form wording is normalized for intelligence display; original source wording remains preserved in product records.

Counts are product presentations, not production or sales volumes.

Shareable intelligence

Equivalent Price Position

Shows whether safely comparable products are below, near or above the peer median unit price.

Equivalent Price PositionPlatinum PharmaceuticalsCurrent company products compared with like-for-like equivalent medicines using normalized unit pricesMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/platinum-pharmaceuticalsGenerated 23 Sep 2026144comparable productsBelow peer median9 · 6%Near peer median38 · 26%Above peer median97 · 67%Company median price position+10.2%Lowest-price equivalents9Method: same generic + stated strength + dosage form + compatible unit basis; pack prices normalized per unit.

This is price-position intelligence, not sales, demand or market-share data.

Shareable intelligence

Closest Portfolio Competitors

Highlights other manufacturers with the greatest generic overlap with this company portfolio.

Closest Portfolio CompetitorsPlatinum PharmaceuticalsCompanies with the largest number of shared generic medicines in the MedInfoBase databaseMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/platinum-pharmaceuticalsGenerated 23 Sep 2026Nabiqasim Industries (Pvt) Ltd.,34 shared61% overlapCCL Pharmaceuticals (Pvt.) Limited30 shared54% overlapMediate Pharmaceutical Pvt Ltd30 shared54% overlapGenome Pharmaceuticals (Pvt.) Ltd.30 shared54% overlapBio-Labs(Pvt) Ltd29 shared52% overlapWerrick Pharmaceuticals28 shared50% overlapPortfolio overlap measures shared generics only; it is not a measure of market share, affiliation or sales competition.

Competitor ranking is based on shared generics in MedInfoBase, not commercial sales performance.

Portfolio intelligence

Therapeutic areas

Broad portfolio view

High-level clinical areas represented by this company’s current MedInfoBase portfolio.

CNS & mental health55 products · 34%
Anti-infectives45 products · 28%
Respiratory & allergy19 products · 12%
Cardiovascular17 products · 11%
Oncology & immunology6 products · 4%
Vitamins, minerals & nutrition5 products · 3%
Reproductive & genitourinary5 products · 3%
Hematology & thrombosis4 products · 2%
Pharmacological detail

Drug classes

More specific view

More specific classes derived from the canonical generic and preserved curated classifications.

Antiepileptics31 products · 19%
Antipsychotics12 products · 7%
Antimalarials12 products · 7%
Antihistamines11 products · 7%
Macrolide antibacterials10 products · 6%
Beta blockers8 products · 5%
SSRI antidepressants8 products · 5%
Immunosuppressants / immunomodulators6 products · 4%
Formulation footprint

Dosage forms

Tablet99 products
Capsule17 products
Suspension15 products
Syrup9 products
Inhalation8 products
Solution7 products
Cream2 products
Pessary2 products
Sachet2 products
How MedInfoBase classifies the portfolio

MedInfoBase uses a two-level taxonomy. Therapeutic area is a broad portfolio category, while drug class is the more specific pharmacological or clinical class. Existing curated classifications are preserved. Blank records are assigned conservatively from the canonical generic name and, when available, ATC information. Multi-use medicines may be placed in a cross-therapeutic category rather than forced into a single indication.

Portfolio leaders

Deepest brand families

Ranked by registered presentations · not sales
#1 LEVOTAMLevetiracetam 11presentations 1 g, 100 MG/mL, 100 mg/mL, 250 mg · Tablet, Solution #2 SEIZUNILCarbamazepine 9presentations 100 mg/5 mL, 200 mg, 400 MG, 400 mg · Suspension, Tablet #3 FEXOFASTFexofenadine 7presentations 120 mg, 180 mg, 30 mg/5 mL, 30 MG/5 mL · Tablet, Solution #4 PLAZOAzithromycin 7presentations 200 mg/5 mL, 250 MG, 500 mg, 500 MG · Suspension, Tablet #5 ARIPAAripiprazole 6presentations 10 mg, 15 mg · Tablet #6 CARDAXENAtenolol 5presentations 100 mg, 25 mg, 50 mg · Tablet
Price intelligence

Unit-price positioning vs equivalent products

Same generic + strength + form + unit basis
Below market median96% of comparable products
Near market median38within ±5% of median
Above market median9767% of comparable products
Lowest-price equivalents9ties included
Company median price position +10.2% relative to the median unit price of like-for-like equivalent products.
Most competitively positioned examplesProducts with at least 3 market comparators
Empanum 10 mgEmpagliflozin · Tablet · 2x7's PKR 46.43/tablet-43.8% vs market median BLICOR 10 mgBisoprolol fumarate · Tablet · 2x10's PKR 14.85/tablet-32.9% vs market median CITALO 20 mgCitalopram · Tablet · 10'S PKR 41.07/tablet-29.1% vs market median BlicorTablet 2.5 mgBisoprolol fumarate · Tablet · 14's PKR 3.22/tablet-24.5% vs market median BlicorTablet 2.5 mgBisoprolol fumarate · Tablet · 10's PKR 3.32/tablet-22.1% vs market median
How MedInfoBase calculates price position

Only current prices with safely interpretable pack quantities are used. A product is compared only with the same generic, same stated strength, same dosage form and a compatible unit basis such as tablet, capsule, mL or gram. These are database-derived price comparisons, not sales or market-share estimates.

Competitive landscape

Portfolio overlap

Companies sharing the largest number of generics with this portfolio. This measures product overlap, not commercial performance.

Nabiqasim Industries (Pvt) Ltd.,365 products · 118 generics 34shared generics CCL Pharmaceuticals (Pvt.) Limited249 products · 99 generics 30shared generics Mediate Pharmaceutical Pvt Ltd236 products · 90 generics 30shared generics Genome Pharmaceuticals (Pvt.) Ltd.181 products · 84 generics 30shared generics Bio-Labs(Pvt) Ltd236 products · 82 generics 29shared generics Werrick Pharmaceuticals249 products · 82 generics 28shared generics
Regulatory & price activity

Observed database signals

Indexed registration numbers107Distinct registrations among indexed, published, presentation-validated products only
Verified price observations167
Products with a verified price161
Products with multiple price observations6
Source records with multiple versions161
Latest portfolio source check22 Sep 2026
Latest effective price date4 Aug 2026
Latest source observation23 Sep 2026

These dates describe records observed by MedInfoBase. They should not be interpreted as product launch dates or sales activity.

Company medicine portfolio

Medicine portfolio

108 unique registration(s) · 161 indexed presentation(s) · 1 additional source-observed presentation(s)

This unified portfolio keeps three evidence lanes distinct: indexed MedInfoBase presentations, additional source-observed presentations, and registry-only registrations that are not otherwise represented. A registration number is not the same thing as a presentation, and source-observed rows are not counted as indexed. Source-only rows with a strength/form/pack contradiction remain visible as evidence but the conflicting field is held for normalization.

Reset
BrandGenericStrengthFormPackRegistrationSource-listed priceUnit pricePrice position
DAPAKAN Divalproex sodium 250 mg Tablet 100'S 024464 PKR 847.74 PKR 8.48/tablet 14% above median
DAPAKAN Divalproex sodium 500 mg Tablet 20'S 024465 PKR 270.22 PKR 13.51/tablet 16% above median
DAPAKAN Divalproex sodium 500 mg Tablet 100'S 024465 PKR 1,323.73 PKR 13.24/tablet 14% above median
DAPAKAN Sodium valproate 250 MG /5 mL Syrup 300ml 024466 PKR 539.11 PKR 1.80/mL No comparator
DAPAKAN Sodium valproate 250 mg/5 mL Syrup 120ml 024466 PKR 220.04 PKR 1.83/mL Near median
DAPAKAN Sodium valproate 250 mg/5 mL Syrup 250ml 024466 PKR 449.25 PKR 1.80/mL Near median
DAPAKAN Sodium valproate 250 MG/5 mL Syrup 60ml 024466 PKR 110.02 PKR 1.83/mL Near median
Empanum Empagliflozin 10 mg Tablet 2x7's 135291 PKR 650.00 PKR 46.43/tablet 44% below median
ESCADAP Escitalopram 10 mg Tablet 14'S 042329 PKR 718.80 PKR 51.34/tablet Near median
ESCADAP Escitalopram 10 mg Tablet 10'S 042329 PKR 513.43 PKR 51.34/tablet Near median
FERTICLO Clomifene citrate 50 mg Tablet 10'S 033928 PKR 458.62 PKR 45.86/tablet 10% above median
FEXOFAST Fexofenadine 60 mg Tablet 10'S 024454 PKR 182.26 PKR 18.23/tablet 49% above median
FEXOFAST Fexofenadine 120 mg Tablet 20's 024455 PKR 625.15 PKR 31.26/tablet 21% above median
FEXOFAST Fexofenadine 120 mg Tablet 10'S 024455 PKR 318.96 PKR 31.90/tablet 24% above median
FEXOFAST Fexofenadine 180 mg Tablet 10'S 024456 PKR 444.26 PKR 44.43/tablet 36% above median
FEXOFAST Fexofenadine 30 MG/5 mL Oral solution 90ML 055703 PKR 193.65 PKR 2.15/mL Near median
FEXOFAST Fexofenadine 30 mg/5 mL Oral solution 30ML 055703 PKR 68.35 PKR 2.28/mL 7% above median
FEXOFAST Fexofenadine 30 mg/5 mL Oral solution 60ML 055703 PKR 125.30 PKR 2.09/mL 6% below median
FLORALAC Lactulose 3.350 g/5 mL Syrup 120ml 021620 PKR 305.67 PKR 2.55/mL No comparator
FLOXOLEV Levofloxacin 250 mg Tablet 10'S 039309 PKR 516.34 PKR 51.63/tablet 8% above median
FLOXOLEV Levofloxacin 500 mg Tablet 10'S 039310 PKR 859.18 PKR 85.92/tablet 9% above median
FUNGIX Fluconazole 150 mg Capsule 1'S 026181 PKR 413.06 PKR 413.06/capsule 57% above median
GRAMEX Metronidazole 400 mg Tablet 100's 023022 PKR 367.96 PKR 3.68/tablet 24% above median
HI-SERVIN Artemether + Lumefantrine 20 mg + 120 mg Tablet 16'S 048503 PKR 660.91 PKR 41.31/tablet 5% above median
HI-SERVIN Artemether + Lumefantrine 40 mg + 240 mg Tablet 8'S 053283 PKR 563.04 PKR 70.38/tablet 10% above median
HI-SERVIN Artemether + Lumefantrine 80 mg + 480 mg Tablet 6'S 061425 PKR 703.80 PKR 117.30/tablet 8% above median
HI-SERVIN DRY Artemether + Lumefantrine 15 mg + 90 mg/5 mL Dry suspension 60ml 053284 PKR 354.68 PKR 5.91/mL Near median
HI-SERVIN DRY Artemether + Lumefantrine 15 mg + 90 mg/5 mL Dry suspension 30ml 053284 PKR 177.35 PKR 5.91/mL Near median
IMUGRAF Ciclosporin 100 mg/mL Solution 50ML 035346 PKR 12,796.42 PKR 255.93/mL No comparator
INOGRAF Tacrolimus 0.5 mg Capsule 30'S 045490 PKR 1,840.49 PKR 61.35/capsule 7% above median
INOGRAF Tacrolimus 0.5 mg Capsule 10'S 045490 PKR 666.84 PKR 66.68/capsule 17% above median
INOGRAF Tacrolimus 1 mg Capsule 30'S 045491 PKR 3,067.50 PKR 102.25/capsule Near median
INOGRAF Tacrolimus 1 mg Capsule 10'S 045491 PKR 1,111.41 PKR 111.14/capsule 14% above median
INOGRAF Tacrolimus 5 mg Capsule 10'S 045492 PKR 5,557.06 PKR 555.71/capsule 9% above median
IPRATIDE INHALER Ipratropium bromide 40 mcg Inhaler 200 METERED DOSE 047320 PKR 394.56 — No comparator
LAMONIL Lamotrigine = 25 mg Tablet 30'S 035604 PKR 648.66 PKR 21.62/tablet Near median
LAMONIL Lamotrigine = 50 mg Tablet 30'S 035605 PKR 864.88 PKR 28.83/tablet Near median
LAMONIL Lamotrigine = 100 mg Tablet 30'S 036299 PKR 1,081.10 PKR 36.04/tablet Near median
LEVOTAM Levetiracetam 500 mg Tablet 30'S 053046 PKR 3,647.03 PKR 121.57/tablet 28% above median
LEVOTAM Levetiracetam 500 MG Tablet 10'S 053046 PKR 1,215.68 PKR 121.57/tablet 28% above median
LEVOTAM Levetiracetam 250 mg Tablet 30'S 053129 PKR 2,199.56 PKR 73.32/tablet 33% above median
LEVOTAM Levetiracetam 250 mg Tablet 10'S 053129 PKR 733.18 PKR 73.32/tablet 33% above median
LEVOTAM Levetiracetam 750 mg Tablet 30'S 055641 PKR 4,290.62 PKR 143.02/tablet 9% above median
LEVOTAM Levetiracetam 750 mg Tablet 10'S 055641 PKR 1,430.21 PKR 143.02/tablet 9% above median
LEVOTAM Levetiracetam 1 g Tablet 30's 055642 PKR 5,363.27 PKR 178.78/tablet 39% above median
LEVOTAM Levetiracetam 1 g Tablet 10's 055642 PKR 1,787.75 PKR 178.78/tablet 39% above median
LEVOTAM Levetiracetam 100 mg/mL Oral solution 60ml 070837 PKR 887.62 PKR 14.79/mL 9% above median
LEVOTAM Levetiracetam 100 MG/mL Oral solution 120ml 070837 PKR 1,775.41 PKR 14.80/mL 9% above median
LEVOTAM Levetiracetam 100 mg/mL Oral solution 60 ML 070837 PKR 739.33 PKR 12.32/mL 9% below median
LIPIX Simvastatin 10 MG Tablet 10'S 026174 PKR 389.24 PKR 38.92/tablet 34% above median
MedInfoBase company-intelligence methodology

This page is generated from MedInfoBase medicine, generic, company, price and official-source records. Unverified third-party discovery records are retained internally for coverage auditing and are not published as company registrations. Portfolio leaders are ranked by presentation depth, not sales. Price-position metrics are calculated from current official-source prices normalized to compatible units and compared only against like-for-like products with the same generic, stated strength and dosage form.

Not currently included: sales volume, revenue by brand, market share, prescription volume or best-selling rankings. MedInfoBase will display those only when supported by a defensible licensed, public or company-verified source.

Cite this record

Manufacturer record
MedInfoBase. (2026). Platinum Pharmaceuticals — registered product portfolio in Pakistan [Data set]. MedInfoBase. Retrieved September 23, 2026, from https://medinfobase.com/company/platinum-pharmaceuticals/
Download .RIS Download .BIB EndNote, Zotero, Mendeley, RefWorks

Records change over time. Please cite the access date so readers can locate the version you used.